Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

733 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation.
Misset JL, Mathé G, Tubiana M, Caillou B, de Vassal F, Pouillart P, Gil M, Tentas C, Hayat M, Schwarzenberg L, Jasmin C, Delgado M, Machover D, Ribaud P, Musset M. Misset JL, et al. Among authors: hayat m. Cancer Chemother Pharmacol. 1978;1(4):197-202. doi: 10.1007/BF00257149. Cancer Chemother Pharmacol. 1978. PMID: 373920 Clinical Trial.
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization.
Misset JL, Mathé G, Tubiana M, Caillou B, de Vassal F, Pouillart P, Gil M, Tentas C, Hayat M, Schwarzenberg L, Jasmin C, Delgado M, Machover D, Ribaud P, Musset M. Misset JL, et al. Among authors: hayat m. Recent Results Cancer Res. 1978;65:188-96. doi: 10.1007/978-3-642-81249-1_23. Recent Results Cancer Res. 1978. PMID: 370939 Clinical Trial.
Preliminary results of a phase II trial of aclacinomycin in acute leukaemia and lymphosarcoma. An oncostatic anthracyclin that is rarely cardiotoxic and induces no alopecia.
Mathé G, Bayssas M, Gouveia J, Dantchev D, Ribaud P, Machover D, Misset JL, Schwarzenberg L, Jasmin C, Hayat M. Mathé G, et al. Among authors: hayat m. Cancer Chemother Pharmacol. 1978;1(4):259-62. doi: 10.1007/BF00257160. Cancer Chemother Pharmacol. 1978. PMID: 373923 Clinical Trial.
Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
Mathé G, Misset JL, De Vassal F, Gouveia J, Hayat M, Machover D, Belpomme D, Pico JL, Schwarzenberg L, Ribaud P, Musset M, Jasmin C, De Luca L. Mathé G, et al. Among authors: hayat m. Cancer Treat Rep. 1978 May;62(5):805-9. Cancer Treat Rep. 1978. PMID: 274996
Leukaemic conversion of non-Hodgkin's malignant lymphomata.
Mathé G, Pouillart P, Schwarzenberg L, Hayat M, Amiel JL, Schlumberger JR, Misset J, Musset M, Jasmin C, De Vassal F. Mathé G, et al. Among authors: hayat m. Br J Cancer Suppl. 1975 Mar;2:96-101. Br J Cancer Suppl. 1975. PMID: 1101938 Free PMC article.
733 results